Next-generation biocontainment systems for engineered organisms

Nature Chemical Biology

Volumn 14, Issue 6, 2018, Pages 530-537

  Lee, Jeong Wook ^a,b   Chan, Clement T Y ^c,d   Slomovic, Shimyn ^a   Collins, James J ^a,c,e,f  

^a HARVARD UNIVERSITY   (United States)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c Massachusetts Institute of Technology   (United States)

^d UNIVERSITY OF TEXAS AT TYLER   (United States)

^e HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SYNTHETIC DNA;

ARTICLE; AUXOTROPHY; BIOLOGICAL FUNCTIONS; BIOSAFETY; CELL FREE SYSTEM; GENETICS; HORIZONTAL GENE TRANSFER; HOST; HUMAN; MUTAGENESIS; PRIORITY JOURNAL; SELF CONCEPT; TRANSGENE; TRANSGENIC ORGANISM; ESCHERICHIA COLI; GENE EDITING; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; GENOME; HAZARDOUS WASTE; LACTOBACILLUS; METABOLISM; PROCEDURES; STOP CODON; SYNTHETIC BIOLOGY;

CODON, TERMINATOR; CONTAINMENT OF BIOHAZARDS; ESCHERICHIA COLI; GENE EDITING; GENE EXPRESSION REGULATION; GENE TRANSFER, HORIZONTAL; GENETIC ENGINEERING; GENOME; HUMANS; LACTOBACILLUS; MUTAGENESIS; ORGANISMS, GENETICALLY MODIFIED; SYNTHETIC BIOLOGY; TRANSGENES;

EID: 85047020981     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/s41589-018-0056-x     Document Type: Article

References (80)

1. Khalil, A. S. & Collins, J. J. Synthetic biology: Applications come of age. Nat. Rev. Genet. 11, 367-379 (2010).
2. Lee, J. W. et al. Systems metabolic engineering of microorganisms for natural and non-natural chemicals. Nat. Chem. Biol. 8, 536-546 (2012).
3. Cameron, D. E., Bashor, C. J. & Collins, J. J. A brief history of synthetic biology. Nat. Rev. Microbiol. 12, 381-390 (2014).
4. Berg, P., Baltimore, D., Brenner, S., Roblin, R. O. & Singer, M. F. Summary statement of the Asilomar conference on recombinant DNA molecules. Proc. Natl Acad. Sci. USA 72, 1981-1984 (1975).
5. Berg, P., Baltimore, D., Brenner, S., Roblin, R. O. III & Singer, M. F. Asilomar conference on recombinant DNA molecules. Science 188, 991-994 (1975).
6. Wilson, D. J. NIH guidelines for research involving recombinant DNA molecules. Account. Res. 3, 177-185 (1993).
7. Sears, M. K. et al. Impact of Bt corn pollen on monarch butterfly populations: A risk assessment. Proc. Natl Acad. Sci. USA 98, 11937-11942 (2001).
8. Stanley-Horn, D. E. et al. Assessing the impact of Cry1Ab-expressing corn pollen on monarch butterfly larvae in field studies. Proc. Natl Acad. Sci. USA 98, 11931-11936 (2001).
9. Snow, A. A. Transgenic crops why gene flow matters. Nat. Biotechnol. 20, 542 (2002).
10. Giovannetti, M. The ecological risks of transgenic plants. Riv. Biol. 96, 207-223 (2003).
11. Hills, M. J., Hall, L., Arnison, P. G. & Good, A. G. Genetic use restriction technologies (GURTs): Strategies to impede transgene movement. Trends Plant Sci. 12, 177-183 (2007).
12. Quist, D. & Chapela, I. H. Transgenic DNA introgressed into traditional maize landraces in Oaxaca, Mexico. Nature 414, 541-543 (2001).
13. Colomer-Lluch, M., Imamovic, L., Jofre, J. & Muniesa, M. Bacteriophages carrying antibiotic resistance genes in fecal waste from cattle, pigs, and poultry. Antimicrob. Agents Chemother. 55, 4908-4911 (2011).
14. Moe-Behrens, G. H., Davis, R. & Haynes, K. A. Preparing synthetic biology for the world. Front. Microbiol. 4, 5 (2013).
15. Dana, G. V., Kuiken, T., Rejeski, D. & Snow, A. A. Synthetic biology: Four steps to avoid a synthetic-biology disaster. Nature 483, 29 (2012).
16. Wright, O., Stan, G. B. & Ellis, T. Building-in biosafety for synthetic biology. Microbiology 159, 1221-1235 (2013).
17. Schmidt, M. & de Lorenzo, V. Synthetic bugs on the loose: Containment options for deeply engineered (micro)organisms. Curr. Opin. Biotechnol. 38, 90-96 (2016).
18. Schmidt, M. & Pei, L. in Hydrocarbon and Lipid Microbiology Protocols: Synthetic and Systems Biology - Tools (eds. McGenity, T.J., Timmis, K.N. & Nogales, B.) 185-199 (Springer Berlin Heidelberg, Berlin, Heidelberg, 2016).
19. Oliver, M. J., Quisenberry, J. E., Trolinder, N. L. G. & Keim, D. H. Control of plant gene expression. US Patent 5, 723, 765 (1998).
20. Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267 (1996).
21. Dull, T. et al. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463-8471 (1998).
22. Burns, J. C., Friedmann, T., Driever, W., Burrascano, M. & Yee, J. K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl Acad. Sci. USA 90, 8033-8037 (1993).
23. Steidler, L. et al. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat. Biotechnol. 21, 785-789 (2003).
24. Bahey-El-Din, M., Casey, P. G., Griffin, B. T. & Gahan, C. G. Efficacy of a Lactococcus lactis Δ pyrG vaccine delivery platform expressing chromosomally integrated hly from Listeria monocytogenes. Bioeng. Bugs 1, 66-74 (2010).
25. Ronchel, M. C. & Ramos, J. L. Dual system to reinforce biological containment of recombinant bacteria designed for rhizoremediation. Appl. Environ. Microbiol. 67, 2649-2656 (2001).
26. Lajoie, M. J. et al. Genomically recoded organisms expand biological functions. Science 342, 357-360 (2013).
27. Rovner, A. J. et al. Recoded organisms engineered to depend on synthetic amino acids. Nature 518, 89-93 (2015).
28. Mandell, D. J. et al. Biocontainment of genetically modified organisms by synthetic protein design. Nature 518, 55-60 (2015).
29. Callura, J. M., Dwyer, D. J., Isaacs, F. J., Cantor, C. R. & Collins, J. J. Tracking, tuning, and terminating microbial physiology using synthetic riboregulators. Proc. Natl Acad Sci. USA 107, 15898-15903 (2010).
30. Gallagher, R. R., Patel, J. R., Interiano, A. L., Rovner, A. J. & Isaacs, F. J. Multilayered genetic safeguards limit growth of microorganisms to defined environments. Nucleic Acids Res. 43, 1945-1954 (2015).
31. Cai, Y. et al. Intrinsic biocontainment: Multiplex genome safeguards combine transcriptional and recombinational control of essential yeast genes. Proc. Natl Acad. Sci. USA 112, 1803-1808 (2015).
32. Agmon, N. et al. Low escape-rate genome safeguards with minimal molecular perturbation of Saccharomyces cerevisiae. Proc. Natl Acad. Sci. USA 114, E1470-E1479 (2017).
33. Huang, S. et al. Coupling spatial segregation with synthetic circuits to control bacterial survival. Mol. Syst. Biol. 12, 859 (2016).
34. Chan, C. T., Lee, J. W., Cameron, D. E., Bashor, C. J. & Collins, J. J. 'Deadman' and 'Passcode' microbial kill switches for bacterial containment. Nat. Chem. Biol. 12, 82-86 (2016).
35. Molina, L., Ramos, C., Ronchel, M. C., Molin, S. & Ramos, J. L. Construction of an efficient biologically contained pseudomonas putida strain and its survival in outdoor assays. Appl. Environ. Microbiol. 64, 2072-2078 (1998).
36. Contreras, A., Molin, S. & Ramos, J. L. Conditional-suicide containment system for bacteria which mineralize aromatics. Appl. Environ. Microbiol. 57, 1504-1508 (1991).
37. Weaver, K. E. The par toxin-antitoxin system from Enterococcus faecalis plasmid pAD1 and its chromosomal homologs. RNA Biol. 9, 1498-1503 (2012).
38. Durand, S., Jahn, N., Condon, C. & Brantl, S. Type I toxin-antitoxin systems in Bacillus subtilis. RNA Biol. 9, 1491-1497 (2012).
39. Diago-Navarro, E. et al. parD toxin-antitoxin system of plasmid R1-basic contributions, biotechnological applications and relationships with closely-related toxin-antitoxin systems. FEBS J. 277, 3097-3117 (2010).
40. Yagura, M., Nishio, S. Y., Kurozumi, H., Wang, C. F. & Itoh, T. Anatomy of the replication origin of plasmid ColE2-P9. J. Bacteriol. 188, 999-1010 (2006).
41. del Solar, G., Giraldo, R., Ruiz-Echevarría, M. J., Espinosa, M. & Díaz-Orejas, R. Replication and control of circular bacterial plasmids. Microbiol. Mol. Biol. Rev. 62, 434-464 (1998).
42. Caliando, B. J. & Voigt, C. A. Targeted DNA degradation using a CRISPR device stably carried in the host genome. Nat. Commun. 6, 6989 (2015).
43. Chavez, A. et al. Precise Cas9 targeting enables genomic mutation prevention. Proc. Natl Acad. Sci. USA https://doi.org/10.1073/pnas.1718148115 (2018).
44. Callaway, E. 'Minimal' cell raises stakes in race to harness synthetic life. Nature 531, 557-558 (2016).
45. Johns, N. I., Blazejewski, T., Gomes, A. L. & Wang, H. H. Principles for designing synthetic microbial communities. Curr. Opin. Microbiol. 31, 146-153 (2016).
46. Mee, M. T., Collins, J. J., Church, G. M. & Wang, H. H. Syntrophic exchange in synthetic microbial communities. Proc. Natl Acad. Sci. USA 111, E2149-E2156 (2014).
47. Wang, K., Neumann, H., Peak-Chew, S. Y. & Chin, J. W. Evolved orthogonal ribosomes enhance the efficiency of synthetic genetic code expansion. Nat. Biotechnol. 25, 770-777 (2007).
48. Neumann, H., Wang, K., Davis, L., Garcia-Alai, M. & Chin, J. W. Encoding multiple unnatural amino acids via evolution of a quadruplet-decoding ribosome. Nature 464, 441-444 (2010).
49. Terasaka, N., Hayashi, G., Katoh, T. & Suga, H. An orthogonal ribosometRNA pair via engineering of the peptidyl transferase center. Nat. Chem. Biol. 10, 555-557 (2014).
50. Soye, B. J. D., Patel, J. R., Isaacs, F. J. & Jewett, M. C. Repurposing the translation apparatus for synthetic biology. Curr. Opin. Chem. Biol. 28, 83-90 (2015).
51. Marlière, P. et al. Chemical evolution of a bacterium's genome. Angew. Chem. Int. Edn. Engl. 50, 7109-7114 (2011).
52. Pinheiro, V. B. et al. Synthetic genetic polymers capable of heredity and evolution. Science 336, 341-344 (2012).
53. Malyshev, D. A. et al. A semi-synthetic organism with an expanded genetic alphabet. Nature 509, 385-388 (2014).
54. Adamala, K. P., Martin-Alarcon, D. A., Guthrie-Honea, K. R. & Boyden, E. S. Engineering genetic circuit interactions within and between synthetic minimal cells. Nat. Chem. 9, 431-439 (2017).
55. Pardee, K. et al. Paper-based synthetic gene networks. Cell 159, 940-954 (2014).
56. Pardee, K. et al. Rapid, low-cost detection of Zika virus using programmable biomolecular components. Cell 165, 1255-1266 (2016).
57. Pardee, K. et al. Portable, on-demand biomolecular manufacturing. Cell 167, 248-259.e12 (2016).
58. Dudley, Q. M., Karim, A. S. & Jewett, M. C. Cell-free metabolic engineering: Biomanufacturing beyond the cell. Biotechnol. J. 10, 69-82 (2015).
59. Garamella, J., Marshall, R., Rustad, M. & Noireaux, V. The All E. coli TX-TL Toolbox 2.0: A platform for cell-free synthetic biology. ACS Synth. Biol. 5, 344-355 (2016).
60. Hong, S. H. et al. Cell-free protein synthesis from a release factor 1 deficient Escherichia coli activates efficient and multiple site-specific nonstandard amino acid incorporation. ACS Synth. Biol. 3, 398-409 (2014).
61. Lu, T. K. & Koeris, M. S. The next generation of bacteriophage therapy. Curr. Opin. Microbiol. 14, 524-531 (2011).
62. Krom, R. J., Bhargava, P., Lobritz, M. A. & Collins, J. J. Engineered phagemids for nonlytic, targeted antibacterial therapies. Nano. Lett. 15, 4808-4813 (2015).
63. Bikard, D. et al. Exploiting CRISPR-Cas nucleases to produce sequencespecific antimicrobials. Nat. Biotechnol. 32, 1146-1150 (2014).
64. Citorik, R. J., Mimee, M. & Lu, T. K. Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat. Biotechnol. 32, 1141-1145 (2014).
65. Ando, H., Lemire, S., Pires, D. P. & Lu, T. K. Engineering modular viral scaffolds for targeted bacterial population editing. Cell Syst. 1, 187-196 (2015).
66. Yosef, I., Manor, M., Kiro, R. & Qimron, U. Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria. Proc. Natl Acad. Sci. USA 112, 7267-7272 (2015).
67. Champer, J., Buchman, A. & Akbari, O. S. Cheating evolution: Engineering gene drives to manipulate the fate of wild populations. Nat. Rev. Genet. 17, 146-159 (2016).
68. DiCarlo, J. E., Chavez, A., Dietz, S. L., Esvelt, K. M. & Church, G. M. Safeguarding CRISPR-Cas9 gene drives in yeast. Nat. Biotechnol. 33, 1250-1255 (2015).
69. Gantz, V. M. & Bier, E. Genome editing. The mutagenic chain reaction: A method for converting heterozygous to homozygous mutations. Science 348, 442-444 (2015).
70. Gantz, V. M. et al. Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi. Proc. Natl Acad. Sci. USA 112, E6736-E6743 (2015).
71. Hammond, A. et al. A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae. Nat. Biotechnol. 34, 78-83 (2016).
72. Wright, O., Delmans, M., Stan, G. B. & Ellis, T. GeneGuard: A modular plasmid system designed for biosafety. ACS Synth. Biol. 4, 307-316 (2015).
73. Molin, S. et al. Conditional suicide system for containment of bacteria and plasmids. Nat. Biotechnol. 5, 1315-1318 (1987).
74. Bej, A. K., Perlin, M. H. & Atlas, R. M. Model suicide vector for containment of genetically engineered microorganisms. Appl. Environ. Microbiol. 54, 2472-2477 (1988).
75. Knudsen, S. M. & Karlström, O. H. Development of efficient suicide mechanisms for biological containment of bacteria. Appl. Environ. Microbiol. 57, 85-92 (1991).
76. Poulsen, L. K., Larsen, N. W., Molin, S. & Andersson, P. A family of genes encoding a cell-killing function may be conserved in all gram-negative bacteria. Mol. Microbiol. 3, 1463-1472 (1989).
77. Braat, H. et al. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin. Gastroenterol. Hepatol. 4, 754-759 (2006).
78. Meinhardt, S. et al. Novel insights from hybrid LacI/GalR proteins: Family-wide functional attributes and biologically significant variation in transcription repression. Nucleic Acids Res. 40, 11139-11154 (2012).
79. Meinhardt, S. & Swint-Kruse, L. Experimental identification of specificity determinants in the domain linker of a LacI/GalR protein: Bioinformaticsbased predictions generate true positives and false negatives. Proteins 73, 941-957 (2008).
80. Taylor, N. D. et al. Engineering an allosteric transcription factor to respond to new ligands. Nat. Methods 13, 177-183 (2016).